Health Insurance Reform Has Surprisingly Little Impact on Actual Health
The typical American’s health compares poorly to that of their counterparts in other high-income countries, even though the U.S. spends twice as much as these countries do on medical care. Behind that middling average lies substantial health inequality. A 40-year-old American male can expect to live 15 years less if he’s one of the poorest 1% of Americans rather than one of the richest 1%. Black children who live in the richest parts of the United States have higher mortality rates than White children in the poorest parts of the country.
[time-brightcove not-tgx=”true”]
Many have put these obser...
Source: TIME: Health - August 18, 2023 Category: Consumer Health News Authors: Liran Einav and Amy Finkelstein Tags: Uncategorized freelance Source Type: news
Serum Ammonia, Hospital Mortality Linked in ICU Cirrhosis Patients
THURSDAY, Aug. 3, 2023 -- For patients with cirrhosis in the intensive care unit (ICU), there is an association between early serum ammonia and hospital mortality, according to a study published online July 20 in Alimentary Pharmacology and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 3, 2023 Category: Pharmaceuticals Source Type: news
Etiology of Cirrhosis Hospitalization Before, During COVID-19 Etiology of Cirrhosis Hospitalization Before, During COVID-19
This study highlights important changes in etiology-specific trends for cirrhosis and decompensated cirrhosis before and during the COVID-19 pandemic in the U.S.Alimentary Pharmacology & Therapeutics (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - July 27, 2023 Category: Intensive Care Tags: Gastroenterology Journal Article Source Type: news
Racial Disparities Seen Among Hospitalized Patients With Decompensated Cirrhosis
WEDNESDAY, July 26, 2023 -- Among individuals hospitalized with decompensated cirrhosis, racial and ethnic disparities in the use of complex life-saving procedures and mortality persist, according to a study published online July 20 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 26, 2023 Category: Pharmaceuticals Source Type: news
Racial Inequalities Persist in Advanced Cirrhosis Care Racial Inequalities Persist in Advanced Cirrhosis Care
Multilevel interventions targeting upstream and downstream factors will be needed to address persistent racial/ethnic disparities in receipt of lifesaving procedures for decompensated cirrhosis.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 22, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Swelling in five areas could signal 'severe' fatty liver disease - what to look for
These symptoms could indicate cirrhosis - where the liver becomes scarred and shrunken. (Source: Daily Express - Health)
Source: Daily Express - Health - July 13, 2023 Category: Consumer Health News Source Type: news
AI plus CT improves cirrhosis prediction in liver disease patients
Adding artificial intelligence (AI) to CT imaging improves the prediction o...Read more on AuntMinnie.comRelated Reading:
AI and CT facilitate opportunistic screening for enlarged spleen
Photon-counting CT just as good as MRI for quantifying liver fat
Multiparametric MRI features can predict liver cancer recurrence
AI can identify hepatocellular carcinoma on liver CT exams
CT, ultrasound provide chance for fatty liver disease screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 13, 2023 Category: Radiology Source Type: news
GLP-1 Agonists Help in Type 2 Diabetes With Liver Cirrhosis GLP-1 Agonists Help in Type 2 Diabetes With Liver Cirrhosis
In adults with cirrhosis and type 2 diabetes, glucagon-like peptide-1 receptor agonist therapy significantly lowered the risk for death and other adverse outcomes, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 30, 2023 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Carvedilol in Cirrhosis Patients With Portal Hypertension Carvedilol in Cirrhosis Patients With Portal Hypertension
Evidence suggests carvedilol may be more effective than other non-selective beta-blockers in reducing portal hypertension in patients with cirrhosis.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 30, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
AI and CT facilitate opportunistic screening for enlarged spleen
Using a deep-learning AI algorithm and weight-based volumetric thresholds wit...Read more on AuntMinnie.comRelated Reading:
Deep-learning CT model helps predict ovarian cancer treatment response
Deep-learning model performs well with CEM images
FDA clears GE HealthCare's deep learning-based image processing software
Spleen stiffness correlates with cirrhosis complication
CT measurement detects splenomegaly (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 29, 2023 Category: Radiology Source Type: news
Naltrexone Is Safe and Beneficial in AUD With Cirrhosis Naltrexone Is Safe and Beneficial in AUD With Cirrhosis
Alcohol abstinence was achieved by nearly two thirds of patients with alcohol use disorder (AUD) and cirrhosis after taking naltrexone, with minimal adverse events.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 26, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Fecal Matter Transplant Shows Promise in Cirrhosis
(MedPage Today) -- VIENNA -- Fecal microbiota transplants (FMT) helped reset gut microbiota, leading to strengthened gut barrier function and mucosal immunity in patients with cirrhosis, according to a U.K. trial.
For this pilot study called... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - June 25, 2023 Category: Surgery Source Type: news
FMT Modifies Gut Microbiome, Reduces Ammonia in Cirrhosis FMT Modifies Gut Microbiome, Reduces Ammonia in Cirrhosis
Fecal microbiota transplant (FMT) promotes restoration of the gut microbiota, enzymes, and immune responses, and reduces ammonia build-up in patients with cirrhosis, a pilot study found.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 23, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Cirrhosis of the Liver: Causes, Symptoms & Treatment
TUESDAY, June 20, 2023 -- Cirrhosis of the liver poses a significant health challenge worldwide. With no known cure, it requires comprehensive management to slow liver damage, alleviate symptoms and prevent potential complications.
Cirrhosis is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 20, 2023 Category: General Medicine Source Type: news
HCV Treatment and Risk of Parkinson's Disease in the DAA Era HCV Treatment and Risk of Parkinson's Disease in the DAA Era
This study found that T2DM and cirrhosis were risk factors for Parkinson ' s disease and secondary parkinsonism in patients with HCV. Does treatment with DAAs significantly impact the risk?Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - June 9, 2023 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
